Will artificial blood be used to treat a patient by the end of 2026?

Low probability for artificial blood use by 2026 suggests skepticism in the market.

The market indicates a significant majority (80.63%) believe artificial blood will not be used to treat patients by the end of 2026. The Pulse AI probability also reflects a similar sentiment but with slightly higher optimism at 24.37%. The edge of 5 suggests that there is insufficient data for a confident assessment of this prediction.

• 1 Current market sentiment leans heavily towards NO.
• 2 The gap between market probability and AI probability indicates uncertainty.
• 3 Confidence level of 55/100 suggests moderate reliability of predictions.
• 4 Time to expiry is substantial, allowing for potential developments.
• 5 Insufficient data limits the ability to make strong predictions.